Aeluma is trading at $7.60, up 6.00% after-hours after CEO Jonathan Klamkin disclosed he terminated a Rule 10b5-1 plan; reporting does not establish the termination as the cause.
- The plan could have allowed sales of up to 300,000 shares; disclosure gave no reason for termination or how many shares, if any, were sold.
- The planned sale’s end may have eased concerns about potential insider selling; broader markets were sharply lower, so Aeluma’s move diverged from their direction.